Gerald M. Walsh

1.0k total citations
51 papers, 824 citations indexed

About

Gerald M. Walsh is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Gerald M. Walsh has authored 51 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Gerald M. Walsh's work include Heart Rate Variability and Autonomic Control (14 papers), Nitric Oxide and Endothelin Effects (6 papers) and Receptor Mechanisms and Signaling (6 papers). Gerald M. Walsh is often cited by papers focused on Heart Rate Variability and Autonomic Control (14 papers), Nitric Oxide and Endothelin Effects (6 papers) and Receptor Mechanisms and Signaling (6 papers). Gerald M. Walsh collaborates with scholars based in United States, Australia and Greece. Gerald M. Walsh's co-authors include E D Frohlich, Masayuki Tsuchiya, R. A. Ferrone, Edward D. Fröhlich, Alfonso J. Tobia, Shanta Bantia, Masayuki Tsuchiya, Steven G. Chrysant, John A. Montgomery and David C. Kem and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Applied Physiology.

In The Last Decade

Gerald M. Walsh

48 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald M. Walsh United States 16 276 242 171 135 73 51 824
Yoshiharu Takiguchi Japan 20 314 1.1× 222 0.9× 302 1.8× 131 1.0× 68 0.9× 95 1.1k
David Hreniuk United States 16 222 0.8× 546 2.3× 127 0.7× 78 0.6× 92 1.3× 28 1.2k
Włodzimierz Buczko Poland 18 367 1.3× 335 1.4× 173 1.0× 62 0.5× 165 2.3× 75 1.2k
Yoshiharu Itoh Japan 20 216 0.8× 757 3.1× 201 1.2× 97 0.7× 190 2.6× 56 1.6k
Jiro Endo Japan 15 188 0.7× 336 1.4× 135 0.8× 55 0.4× 239 3.3× 68 834
B. J. Northover United Kingdom 17 209 0.8× 385 1.6× 216 1.3× 39 0.3× 122 1.7× 72 1.1k
Yoshiaki Yamashita Japan 13 162 0.6× 157 0.6× 248 1.5× 51 0.4× 93 1.3× 41 679
Hiroshi Tsuchihashi Japan 17 67 0.2× 330 1.4× 157 0.9× 149 1.1× 63 0.9× 77 779
Norbert Vrbjar Slovakia 15 157 0.6× 391 1.6× 222 1.3× 55 0.4× 117 1.6× 77 810
Norbert Kolassa Germany 20 152 0.6× 629 2.6× 147 0.9× 86 0.6× 37 0.5× 54 1.3k

Countries citing papers authored by Gerald M. Walsh

Since Specialization
Citations

This map shows the geographic impact of Gerald M. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald M. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald M. Walsh more than expected).

Fields of papers citing papers by Gerald M. Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald M. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald M. Walsh. The network helps show where Gerald M. Walsh may publish in the future.

Co-authorship network of co-authors of Gerald M. Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald M. Walsh. A scholar is included among the top collaborators of Gerald M. Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald M. Walsh. Gerald M. Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lau, Joseph T. F., et al.. (2025). Mitochondria at the Heart of Sepsis: Mechanisms, Metabolism, and Sex Differences. International Journal of Molecular Sciences. 26(9). 4211–4211. 1 indexed citations
2.
Tine, Brian A. Van, Mark Agulnik, Richard D. Olson, et al.. (2019). A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma. Cancer Medicine. 8(6). 2994–3003. 9 indexed citations
3.
4.
Holstein, Sarah A., James C. Bigelow, Richard D. Olson, et al.. (2015). Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors. Investigational New Drugs. 33(3). 594–602. 6 indexed citations
5.
Olson, Richard D., et al.. (2007). In vitro and in vivo immunosuppressive activity of a novel anthracycline, 13-deoxy, 5-iminodoxorubicin. International Immunopharmacology. 7(6). 734–743. 9 indexed citations
6.
Gambliel, Hervé A., et al.. (2002). Doxorubicin and C-13 Deoxydoxorubicin Effects on Ryanodine Receptor Gene Expression. Biochemical and Biophysical Research Communications. 291(3). 433–438. 33 indexed citations
7.
Conry, Robert M., Shanta Bantia, D L Barlow, et al.. (1998). Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells. Immunopharmacology. 40(1). 1–9. 15 indexed citations
8.
Lu, Zhihong, et al.. (1997). High-performance liquid chromatographic determination of 9-(3-pyridylmethyl)-9-deazaguanine (BCX-34) in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 690(1-2). 295–303. 2 indexed citations
9.
Bantia, Shanta, John A. Montgomery, Harry G. Johnson, & Gerald M. Walsh. (1996). In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP. Immunopharmacology. 35(1). 53–63. 27 indexed citations
10.
Montgomery, John A., et al.. (1993). BCX-34. Drugs of the Future. 18(10). 887–887. 14 indexed citations
11.
Salyers, Anita K., et al.. (1988). Simultaneous determination of ventricular function and systemic hemodynamics in the conscious rat. Journal of Pharmacological Methods. 19(3). 267–274. 11 indexed citations
12.
Lee, Jang Y., et al.. (1988). Effects of verapamil and nifedipine on systemic hemodynamics in spontaneously hypertensive rats. Journal of Hypertension. 6(12). 1017–1022. 3 indexed citations
13.
Spokas, Eric G., et al.. (1987). Cardiovascular effects of chronic high-dose atriopeptin III infusion in normotensive rats. Toxicology and Applied Pharmacology. 91(3). 305–314. 4 indexed citations
14.
Walsh, Gerald M.. (1983). Increased Systemic Vascular Responsiveness to Catecholamines in Spontaneously Hypertensive Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 5(4). 577–601. 10 indexed citations
15.
Lee, Jang Y., et al.. (1981). Reflex cardiovascular responses induced by electrical stimulation of glossopharyngeal nerves in the rat. Journal of Pharmacological Methods. 5(1). 15–27. 1 indexed citations
16.
Walsh, Gerald M., R. A. Ferrone, Masayuki Tsuchiya, E. F. Woods, & Edward Charles DeLand. (1980). Hemodynamic and metabolic responses to repeated blood sampling in the rat. American Journal of Physiology-Heart and Circulatory Physiology. 239(6). H805–H809. 20 indexed citations
17.
Tsuchiya, Masayuki, Gerald M. Walsh, & E D Frohlich. (1977). Systemic hemodynamic effects of microspheres in conscious rats. American Journal of Physiology-Heart and Circulatory Physiology. 233(5). H617–H621. 47 indexed citations
18.
Walsh, Gerald M., Masayuki Tsuchiya, & Edward D. Fröhlich. (1976). Direct Fick application for measurement of cardiac output in rat. Journal of Applied Physiology. 40(5). 849–853. 19 indexed citations
19.
Sternson, Larry A., et al.. (1974). THE METABOLISM OF BETAHISTINE IN THE RAT. Drug Metabolism and Disposition. 2(2). 123–128. 11 indexed citations
20.
Tobia, Alfonso J., Larry A. Sternson, & Gerald M. Walsh. (1974). The Role of Demethylbetahistine in the Depressor Response to Betahistine in the Rat. Experimental Biology and Medicine. 145(3). 778–781. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiharu Takiguchi Breakdown of academic impact, for papers by David Hreniuk Breakdown of academic impact, for papers by Włodzimierz Buczko Breakdown of academic impact, for papers by Yoshiharu Itoh Breakdown of academic impact, for papers by Jiro Endo Breakdown of academic impact, for papers by B. J. Northover Breakdown of academic impact, for papers by Yoshiaki Yamashita Breakdown of academic impact, for papers by Hiroshi Tsuchihashi Breakdown of academic impact, for papers by Norbert Vrbjar Breakdown of academic impact, for papers by Norbert Kolassa
Rankless by CCL
2026